Your browser doesn't support javascript.
loading
An in-silico analysis of ivermectin interaction with potential SARS-CoV-2 targets and host nuclear importin α.
Azam, Faizul; Taban, Ismail M; Eid, Eltayeb E M; Iqbal, Muzaffar; Alam, Ozair; Khan, Shamshir; Mahmood, Danish; Anwar, Md Jamir; Khalilullah, Habibullah; Khan, M U.
Afiliación
  • Azam F; Department of Pharmaceutical Chemistry & Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Saudi Arabia.
  • Taban IM; School of Biosciences, Cardiff University, Cardiff, U.K.
  • Eid EEM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Misurata University, Misurata, Libya.
  • Iqbal M; Department of Pharmaceutical Chemistry & Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Saudi Arabia.
  • Alam O; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Khan S; Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, New Delhi, India.
  • Mahmood D; Department of Pharmaceutical Chemistry, Dentistry and Pharmacy College, Buraydah Private Colleges, Buraydah, Al-Qassim.
  • Anwar MJ; Department of Pharmacology & Toxicology, Unaizah College of Pharmacy, Qassim University, Saudi Arabia.
  • Khalilullah H; Department of Pharmacology & Toxicology, Unaizah College of Pharmacy, Qassim University, Saudi Arabia.
  • Khan MU; Department of Pharmaceutical Chemistry & Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Saudi Arabia.
J Biomol Struct Dyn ; 40(6): 2851-2864, 2022 04.
Article en En | MEDLINE | ID: mdl-33131430
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ivermectina / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: J Biomol Struct Dyn Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ivermectina / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: J Biomol Struct Dyn Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Reino Unido